Budesonide oral suspension (Eohilia) for eosinophilic esophagitis. | Med Lett Drugs Ther;66(1704): 93-95, 2024 Jun 10. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Budesonide oral suspension (Eohilia) for eosinophilic esophagitis.

Med Lett Drugs Ther ; 66(1704): 93-95, 2024 Jun 10.

Article in En | MEDLINE | ID: mdl-38905533

Subject(s)
Key words

Dupixent; Eohilia; PPIs; Pulmicort; adverse effects; budesonide; dosage; drug interactions; dupilumab; efficacy; eosinophilic esophagitis; lactation; pregnancy; safety; topical steroids

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Suspensions / Budesonide / Eosinophilic Esophagitis Limits: Humans Language: En Journal: Med Lett Drugs Ther / Med. lett. drugs ther. (ed. esp.) / Medical letter on drugs and therapeutics (ed. espanol) Year: 2024 Document type: Article Country of publication: Estados Unidos

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Suspensions / Budesonide / Eosinophilic Esophagitis Limits: Humans Language: En Journal: Med Lett Drugs Ther / Med. lett. drugs ther. (ed. esp.) / Medical letter on drugs and therapeutics (ed. espanol) Year: 2024 Document type: Article Country of publication: Estados Unidos